$347 Million is the total value of DAFNA Capital Management LLC's 87 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 33.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $61,015,000 | +47.7% | 13,680,554 | 0.0% | 17.61% | +2.1% | |
| BPMC | BLUEPRINT MEDICINES CORP | $17,791,000 | +33.4% | 228,089 | 0.0% | 5.13% | -7.8% | |
| FATE | Buy | FATE THERAPEUTICS INC | $16,841,000 | +61.3% | 490,861 | +4.4% | 4.86% | +11.6% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $15,432,000 | +104.5% | 245,142 | +36.5% | 4.45% | +41.4% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $11,538,000 | +325.1% | 454,236 | +207.5% | 3.33% | +193.9% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $10,357,000 | +60.1% | 762,666 | -10.6% | 2.99% | +10.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $8,931,000 | +28.7% | 73,208 | -8.7% | 2.58% | -11.0% |
| IMMU | New | IMMUNOMEDICS INC | $8,892,000 | – | 250,905 | +100.0% | 2.57% | – |
| GLPG | Sell | GALAPAGOS NVspon adr | $8,755,000 | -3.6% | 44,375 | -4.3% | 2.53% | -33.4% |
| DXCM | Sell | DEXCOM INC | $8,569,000 | -4.5% | 21,138 | -36.6% | 2.47% | -34.0% |
| PRQR | PROQR THERAPEUTICS N V | $7,523,000 | +10.7% | 1,237,400 | 0.0% | 2.17% | -23.4% | |
| IBB | Sell | ISHARES TR NASDAQ BIOTECHetf | $7,504,000 | -4.5% | 54,900 | -24.7% | 2.17% | -33.9% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDG I | $6,965,000 | +874.1% | 149,017 | +183.4% | 2.01% | +574.5% |
| SAGE | SAGE THERAPEUTICS INC | $6,873,000 | +44.8% | 165,306 | 0.0% | 1.98% | +0.1% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $6,431,000 | +68.9% | 1,160,878 | 0.0% | 1.86% | +16.8% | |
| BHVN | Sell | BIOHAVEN PHARMACEUTICALS HOLD | $6,404,000 | +107.7% | 87,600 | -3.3% | 1.85% | +43.6% |
| CARA | CARA THERAPEUTICS INC | $6,345,000 | +29.5% | 371,033 | 0.0% | 1.83% | -10.5% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $6,322,000 | +170.1% | 270,163 | -32.7% | 1.82% | +86.7% |
| ATRC | Sell | ATRICURE INC | $5,989,000 | -25.6% | 133,229 | -44.4% | 1.73% | -48.6% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $5,335,000 | – | 360,000 | +100.0% | 1.54% | – |
| CGEN | Sell | COMPUGEN LTDord | $5,153,000 | +18.3% | 343,046 | -42.8% | 1.49% | -18.2% |
| CNST | New | CONSTELLATION PHARMACEUTICAL | $5,137,000 | – | 170,942 | +100.0% | 1.48% | – |
| LMNX | Sell | LUMINEX CORP | $5,013,000 | -10.8% | 154,091 | -24.5% | 1.45% | -38.3% |
| KURA | Sell | KURA ONCOLOGY INC | $4,796,000 | +56.7% | 294,260 | -4.3% | 1.38% | +8.4% |
| CSII | Buy | CARDIOVASCULAR SYSTEMS INC | $4,770,000 | +164.6% | 151,200 | +195.3% | 1.38% | +83.1% |
| LQDA | New | LIQUIDIA TECHNOLOGIES INC | $4,631,000 | – | 550,000 | +100.0% | 1.34% | – |
| XENE | XENON PHARMACEUTICALS INC | $4,346,000 | +10.6% | 346,535 | 0.0% | 1.25% | -23.5% | |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $4,125,000 | +4.1% | 279,440 | -4.8% | 1.19% | -28.0% |
| AFMD | Sell | AFFIMED NV | $3,900,000 | +117.8% | 845,000 | -25.4% | 1.13% | +50.7% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $3,545,000 | +270.0% | 744,051 | +55.3% | 1.02% | +155.8% |
| ALEC | Sell | ALECTOR INC | $3,422,000 | -8.5% | 140,000 | -9.7% | 0.99% | -36.7% |
| VKTX | VIKING THERAPEUTICS INC | $3,251,000 | +54.1% | 450,900 | 0.0% | 0.94% | +6.5% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $2,990,000 | +5.7% | 4,000,000 | 0.0% | 0.86% | -26.9% | ||
| KDMN | Sell | KADMON HOLDINGS INC | $2,834,000 | +21.5% | 553,564 | -0.5% | 0.82% | -15.9% |
| AXGT | Sell | AXOVANT GENE THERAPIES LTD | $2,835,000 | +13.7% | 1,005,391 | -1.6% | 0.82% | -21.3% |
| BEAT | BIOTELEMETRY INC | $2,734,000 | +17.3% | 60,500 | 0.0% | 0.79% | -18.8% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $2,692,000 | +49.8% | 222,452 | -5.3% | 0.78% | +3.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $2,500,000 | -22.7% | 21,893 | -48.0% | 0.72% | -46.6% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $2,106,000 | -44.6% | 14,237 | -57.8% | 0.61% | -61.6% |
| BLUE | Buy | BLUEBIRD BIO INC | $1,848,000 | +57.7% | 30,273 | +18.7% | 0.53% | +9.0% |
| ISEE | New | IVERIC BIO INC | $1,823,000 | – | 357,500 | +100.0% | 0.53% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $1,784,000 | +362.2% | 72,100 | +159.4% | 0.52% | +219.9% |
| OTIC | OTONOMY INC | $1,698,000 | +83.8% | 469,135 | 0.0% | 0.49% | +26.9% | |
| LRMR | New | LARIMAR THERAPEUTICS INC | $1,622,000 | – | 126,261 | +100.0% | 0.47% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $1,499,000 | -28.4% | 23,210 | -50.5% | 0.43% | -50.5% |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $1,474,000 | +38.9% | 320,542 | 0.0% | 0.42% | -4.1% | |
| HARP | Sell | HARPOON THERAPEUTICS INC | $1,413,000 | -17.3% | 85,119 | -42.3% | 0.41% | -42.8% |
| ZGNX | Sell | ZOGENIX INC | $1,371,000 | -61.3% | 50,749 | -64.6% | 0.40% | -73.2% |
| ARAY | ACCURAY INC | $1,369,000 | +6.9% | 674,300 | 0.0% | 0.40% | -26.2% | |
| JNJ | JOHNSON AND JOHNSON | $1,322,000 | +7.2% | 9,400 | 0.0% | 0.38% | -25.8% | |
| ARDX | ARDELYX INC | $1,279,000 | +21.7% | 184,850 | 0.0% | 0.37% | -15.9% | |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $1,207,000 | +29.4% | 524,664 | -3.3% | 0.35% | -10.5% |
| PRVL | PREVAIL THERAPEUTICS INC | $1,118,000 | +22.3% | 75,000 | 0.0% | 0.32% | -15.2% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $1,096,000 | -24.3% | 33,554 | -37.9% | 0.32% | -47.7% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $1,029,000 | +129.2% | 9,231 | +48.1% | 0.30% | +58.8% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $1,030,000 | -21.8% | 64,235 | -70.8% | 0.30% | -46.0% |
| STIM | NEURONETICS INC | $957,000 | +2.1% | 495,772 | 0.0% | 0.28% | -29.4% | |
| NTUS | NATUS MEDICAL INC | $936,000 | -5.6% | 42,900 | 0.0% | 0.27% | -34.8% | |
| HOOK | New | HOOKIPA PHARMA INC | $931,000 | – | 80,118 | +100.0% | 0.27% | – |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $907,000 | -76.8% | 108,061 | -85.5% | 0.26% | -84.0% |
| ASMB | ASSEMBLY BIOSCIENCES INC | $830,000 | +57.2% | 35,573 | 0.0% | 0.24% | +9.1% | |
| SLNO | New | SOLENO THERAPEUTICS INC | $827,000 | – | 372,500 | +100.0% | 0.24% | – |
| CERC | New | CERECOR INC | $827,000 | – | 318,000 | +100.0% | 0.24% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $826,000 | +102.5% | 106,444 | +166.1% | 0.24% | +40.0% |
| SYBX | Sell | SYNLOGIC INC | $819,000 | -4.9% | 403,597 | -19.4% | 0.24% | -34.3% |
| MORF | Sell | MORPHIC HOLDING INC | $812,000 | +49.5% | 30,000 | -18.9% | 0.23% | +3.1% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $747,000 | -17.7% | 6,600 | -51.5% | 0.22% | -43.0% |
| SCPH | New | SCPHARMACEUTICALS INC | $736,000 | – | 100,000 | +100.0% | 0.21% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $709,000 | +16.2% | 46,183 | -41.4% | 0.20% | -19.6% |
| MASI | MASIMO CORPORATION | $684,000 | +28.8% | 3,000 | 0.0% | 0.20% | -11.3% | |
| ZYME | Sell | ZYMEWORKS INC | $651,000 | -42.6% | 18,039 | -43.6% | 0.19% | -60.3% |
| GMDA | Sell | GAMIDA CELL LTD | $640,000 | +42.5% | 140,000 | -5.9% | 0.18% | -1.1% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $578,000 | – | 165,600 | +100.0% | 0.17% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $575,000 | – | 275,000 | +100.0% | 0.17% | – |
| INGN | Sell | INOGEN INC | $533,000 | -55.1% | 15,000 | -34.8% | 0.15% | -69.0% |
| ALRN | New | AILERON THERAPEUTICS INC | $531,000 | – | 450,000 | +100.0% | 0.15% | – |
| NXTC | NEXTCURE INC | $429,000 | -42.1% | 20,000 | 0.0% | 0.12% | -59.9% | |
| ETNB | New | 89BIO INC | $408,000 | – | 20,478 | +100.0% | 0.12% | – |
| PRVB | New | PROVENTION BIO INC | $353,000 | – | 25,000 | +100.0% | 0.10% | – |
| GRTS | GRITSTONE ONCOLOGY INC | $332,000 | +14.1% | 50,000 | 0.0% | 0.10% | -20.7% | |
| RDUS | RADIUS HEALTH INC | $300,000 | +4.9% | 22,000 | 0.0% | 0.09% | -26.9% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $289,000 | +17.5% | 157,700 | 0.0% | 0.08% | -19.4% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $235,000 | – | 76,800 | +100.0% | 0.07% | – |
| MEIP | New | MEI PHARMA INC | $227,000 | – | 55,000 | +100.0% | 0.07% | – |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $172,000 | +95.5% | 86,082 | 0.0% | 0.05% | +35.1% | |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $83,000 | +5.1% | 95,000 | 0.0% | 0.02% | -27.3% | |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $51,000 | -93.4% | 6,100 | -93.9% | 0.02% | -95.3% |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -2,369 | -100.0% | -0.02% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -4,614 | -100.0% | -0.04% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -305,500 | -100.0% | -0.10% | – |
| ELOX | Exit | ELOXX PHARMACEUTICALS INC | $0 | – | -191,494 | -100.0% | -0.16% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -48,103 | -100.0% | -0.16% | – |
| XCUR | Exit | EXICURE INC | $0 | – | -275,000 | -100.0% | -0.17% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -4,471 | -100.0% | -0.25% | – |
| Exit | DEXCOM INCnote 0.750% 5/1 | $0 | – | -250,000 | -100.0% | -0.29% | – | |
| MGNX | Exit | MACROGENICS INC | $0 | – | -150,000 | -100.0% | -0.36% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -105,900 | -100.0% | -0.69% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.